Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMYOTROPHIC LATERAL SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00718003
What this trial is testing

Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).

Who this might be right for
Amyotrophic Lateral SclerosisNeurodegenerative DiseaseMotor Neuron Disease
Drexel University College of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00036413
What this trial is testing

A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Novartis Pharmaceuticals 44
Not applicableLooking for participantsNCT06885918
What this trial is testing

ALS Research Collaborative

Who this might be right for
Amyotrophic Lateral SclerosisALS (Amyotrophic Lateral Sclerosis)ALS With Frontotemporal Dementia (ALS/FTD)+2 more
ALS Therapy Development Institute 2,000
Testing effectiveness (Phase 2)Study completedNCT02460679
What this trial is testing

Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
PTC Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT03427086
What this trial is testing

Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
American University of Beirut Medical Center 12
Not applicableStudy completedNCT02236897
What this trial is testing

PET Imaging in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Johns Hopkins University 36
Early research (Phase 1)Ended earlyNCT01999803
What this trial is testing

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Newron Sweden AB 15
Not applicableUnknownNCT03545451
What this trial is testing

Neurofeedback Rehabilitation Based on Motor Imaging in Patients in the Immobilization Phase

Who this might be right for
Healthy Subjects, Patients With Amyotrophic Lateral Sclerosis, Patients With Shoulder Surgery
Assistance Publique - Hôpitaux de Paris 30
Not applicableStudy completedNCT03154450
What this trial is testing

EncoreAnywhere Use in Motor Neurone Disease

Who this might be right for
Motor Neuron Disease
Sheffield Teaching Hospitals NHS Foundation Trust 19
Not applicableStudy completedNCT05562960
What this trial is testing

Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP

Who this might be right for
Amyotrophic Lateral SclerosisPlasmapheresis
National Taiwan University Hospital 5
Not applicableLooking for participantsNCT07312240
What this trial is testing

LONgitudinal and Integrated Evaluation of Biomarkers in reLation to phenotYpe in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Istituto Auxologico Italiano 140
Not applicableStudy completedNCT02590276
What this trial is testing

Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Frontotemporal Lobar DegenerationAmyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris 100
Not applicableLooking for participantsNCT06608004
What this trial is testing

Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Centre Hospitalier Universitaire Dijon 60
Not applicableStudy completedNCT02670226
What this trial is testing

Muscular Biomarkers in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Tours 37
Not applicableStudy completedNCT03095989
What this trial is testing

An Online Mindfulness Intervention for People With ALS and Their Caregivers

Who this might be right for
Amyotrophic Lateral Sclerosis
Harvard University 100
Not applicableLooking for participantsNCT07380204
What this trial is testing

Quantification of Hsp90 in the Human Brain

Who this might be right for
Parkinson's Disease (PD)Alzheimer's Disease (AD)Amyotrophic Lateral Sclerosis (ALS)
Universitaire Ziekenhuizen KU Leuven 48
Not applicableUnknownNCT03900247
What this trial is testing

Restore Motor Function Through Robotic Arm Exoskeleton and Brain Computer Interface

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Aarhus 15
Large-scale testing (Phase 3)Looking for participantsNCT07161999
What this trial is testing

Study of COYA 302 for the Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Coya Therapeutics 120
Large-scale testing (Phase 3)Looking for participantsNCT06126315
What this trial is testing

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Mario Negri Institute for Pharmacological Research 246
Early research (Phase 1)Study completedNCT04894240
What this trial is testing

Monepantel in Individuals With Motor Neurone Disease

Who this might be right for
Motor Neuron Disease
Neurizon Therapeutics Limited 12
Next Page